⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for "Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: "Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"

Official Title: "Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"

Study ID: NCT05299580

Conditions

Melanoma

Study Description

Brief Summary: There is evidence from cohort studies and metanalysis that a shift from BRAFWT to BRAF mutated melanomas can occur (Colombino JCO 2012, Valchis EJC 2017). Based on previous studies we expect that 15% of tissue BRAF WT patients treated with anti PD-1 will become circulating free DNA BRAF (CfDNA BRAF) mutation-positive and, at progression, they will be elegible to be treated with dabrafenib/trametinib. We aimed to design a clinical phase II trial in order to evaluate the activity of Dabrafenib and Trametinib in patients with Tissue BRAFWT signature and a molecular shift to circulating free DNA BRAF mutated positive melanomas upon progression to anti PD-1 therapy.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l., Meldola, Forlì-Cesena, Italy

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, Alessandria, , Italy

National Institute of Cancer, Bari, , Italy

Università degli Studi di Bari Aldo Moro, Bari, , Italy

AOU Sant'Orsola-Malpighi, Bologna, , Italy

ASST Spedali Civili Brescia, Brescia, , Italy

Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, , Italy

IRCCS San Martino - IST, Genova, , Italy

Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori, Milano, , Italy

Azienda Ospedaliera Universitaria di Modena, Modena, , Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale", Naples, , Italy

Istituto Oncologico Veneto, Padova, , Italy

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, , Italy

Istituto Nazionale Tumori Regina Elena, Roma, , Italy

Azienda Ospedaliera Universitaria - Città della Salute e della Scienza di Torino, Torino, , Italy

Azienda Ospedaliera Universitaria Integrata di Udine, Udine, , Italy

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: